Homebiopharmaceutical

biopharmaceutical

FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Celsion Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Celsion Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

December 29, 2020

FBIO, NAK & SPLK Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm

FBIO, NAK & SPLK Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm

December 29, 2020

CLSN Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Celsion Corporation Shareholders With Losses Exceeding $150K of Class Action and Lead Plaintiff Deadline: December 28, 2020

CLSN Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Celsion Corporation Shareholders With Losses Exceeding $150K of Class Action and Lead Plaintiff Deadline: December 28, 2020

December 29, 2020

Ampio Receives feedback from the FDA on Ampio’s Proposed Modifications to the special protocol assessment for Ampion treatment of severe Osteoarthritis of the knee

Ampio Receives feedback from the FDA on Ampio’s Proposed Modifications to the special protocol assessment for Ampion treatment of severe Osteoarthritis of the knee

December 29, 2020

Capricor Therapeutics Announces DSMB Recommendation to Continue Phase II INSPIRE Trial for Severe COVID-19 Patients

Capricor Therapeutics Announces DSMB Recommendation to Continue Phase II INSPIRE Trial for Severe COVID-19 Patients

December 29, 2020

FINAL CLSN DEADLINE TODAY: ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Celsion Corporation Investors of Important Tuesday Deadline in Securities Class Action – CLSN

FINAL CLSN DEADLINE TODAY: ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Celsion Corporation Investors of Important Tuesday Deadline in Securities Class Action – CLSN

December 29, 2020

Actinium Announces Successful Pre-Planned Ad Hoc Interim Analysis of Phase 3 SIERRA trial

Actinium Announces Successful Pre-Planned Ad Hoc Interim Analysis of Phase 3 SIERRA trial

December 29, 2020

Hepion Pharmaceuticals Data Safety Monitoring Board Recommends Continuation with Final Dose Cohort in Phase 2a ‘AMBITION’ Clinical Trial for Treatment of Advanced NASH

Hepion Pharmaceuticals Data Safety Monitoring Board Recommends Continuation with Final Dose Cohort in Phase 2a ‘AMBITION’ Clinical Trial for Treatment of Advanced NASH

December 29, 2020

SHAREHOLDER ALERT: WeissLaw LLP Reminds SFBK, EV, WDR, and CBLI Shareholders About Its Ongoing Investigations

SHAREHOLDER ALERT: WeissLaw LLP Reminds SFBK, EV, WDR, and CBLI Shareholders About Its Ongoing Investigations

December 28, 2020

SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Companies – CBLI, IPHI, CBMG, WTRE, CIT

SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Companies – CBLI, IPHI, CBMG, WTRE, CIT

December 28, 2020

« 1 … 537 538 539 540 541 … 558 »